20Jan/14

European Approval for Gilead Drug – Analyst Blog – NASDAQ


Witney Gazette

European Approval for Gilead Drug – Analyst Blog
NASDAQ
The EC cleared the drug as an all-oral therapy for treating patients affected with genotypes 1, 2, 3, 4, 5 or 6 of the virus. Sovaldi in combination with ribavirin can also be used to treat chronic HCV patients awaiting liver transplantation to prevent
EU clears Gilead’s hepatitis C therapy SovaldiPMLiVE
European Commission grants marketing authorization for Gilead’s SovaldiPharmaceutical Business Review
Gilead Sciences Inc receives marketing authorisation for Sovaldi for treating MENAFN.COM
expressandstar.com
all 21 news articles »
20Jan/14

The case for a kidney marketplace – PBS NewsHour


PBS NewsHour

The case for a kidney marketplace
PBS NewsHour
Paying kidney donors for their organs may help to close the growing supply gap for transplant surgery in the United States, say two prominent economists. Nobel-prize winning economist Gary Becker and colleague Julio Elias made waves Sunday in an essay 
Response to: “Cash for Kidneys: The Case for a Market for Organs”ScienceBlog.com (blog)
Pressuring Poor People to Sell Their Organs: Economists Push “Cash for Kidneys”LifeNews.com
Cash for Kidneys: The Case for a Market for OrgansWall Street Journal

all 15 news articles »